摘要
背景:高骨量(HBM)病是一组临床和遗传异质性的骨疾病的增加骨密度片,由于渐进性骨overgro随着或受损的骨吸收,或两者。一些HBM的病例是继发于其他疾病,如慢性丙型肝炎病毒感染。尽管在基因诊断技术的巨大进步,主要HBM的个体性仍然确诊。 目的:总结不同病因所致HBM患者的临床、影像学及生化特征,为鉴别诊断提供依据。HBM的无菌性。 结果:HBM各亚组均有不同的临床、影像学和生化特征。由于骨骼过度生长,hbm被指定为硬皮病,其原因是loc突变。与Wnt/β-catenin信号通路密切相关的基因。编码与破骨细胞分化和成熟相关的基因突变,或对酸化因子至关重要的基因突变阳离子和骨吸收的破骨细胞可导致骨硬化症。丙型肝炎相关性硬化的特点是骨量广义增加显着升高血清骨特异性碱性磷酸酶。 结论:阐明HBM的病因对了解骨代谢的分子机制具有重要的突破作用,为骨代谢的介入提供了新的途径。骨质疏松症。
关键词: 高骨量,成骨细胞,破骨细胞,硬化,骨硬化,Wnt/β-catenin信号,丙型肝炎相关骨硬化。
Current Drug Targets
Title:A Review of the Clinical, Radiological and Biochemical Characteristics and Genetic Causes of High Bone Mass Disorders
Volume: 19 Issue: 6
关键词: 高骨量,成骨细胞,破骨细胞,硬化,骨硬化,Wnt/β-catenin信号,丙型肝炎相关骨硬化。
摘要: Background: High bone mass (HBM) disorders are a group of clinically and genetically heterogeneous bone diseases characterized by increased bone density on radiographs, due to progressive bone overgrowth or impaired bone resorption, or both. Some HBM cases are secondary to other diseases, such as chronic hepatitis C virus infection. Despite the great advance in gene diagnostic technology, the majority of HBM individuals remain undiagnosed.
Objective: In this review, we will summarize the clinical, radiological and biochemical characteristics of HBM cases due to varying etiologies, since these features are helpful in the differential diagnosis of HBM.
Results: Each subgroup of HBM cases shows distinctive clinical, radiological and biochemical characteristics. HBM, due to bone overgrowth, was designated as sclerosteosis, as a result of mutations located in genes critically involved in the Wnt/beta-catenin signal pathway. Mutations in genes encoding factors relevant to the differentiation and maturation of osteoclasts, or critical for the acidification and resorption of osteoclasts may lead to osteopetrosis. Hepatitis C associated osteosclerosis is characterized by a generalized increase in bone mass and markedly elevated serum levels of bone specific alkaline phosphatase.
Conclusion: The clarification of the etiologies of HBM may have a breakthrough role in understanding the molecular mechanisms involved in bone metabolism and may provide new pathways for the intervention of osteoporosis.
Export Options
About this article
Cite this article as:
A Review of the Clinical, Radiological and Biochemical Characteristics and Genetic Causes of High Bone Mass Disorders, Current Drug Targets 2018; 19 (6) . https://dx.doi.org/10.2174/1389450119666180122161503
DOI https://dx.doi.org/10.2174/1389450119666180122161503 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
Drug-Targeted Approach with Polymer Nanocomposites for Improved Therapeutics
Polymer nanocomposites have been recognized as an advanced and cutting-edge technique in drug targeting administration. These materials combine the unique features of nanoparticles with the adaptability of polymers to produce highly personalized drug administration devices. Integrating nanoparticles containing pharmaceuticals into a polymer matrix enables researchers to regulate the rates at ...read more
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
Therapeutic Chemical and RNA Design with Artificial Intelligence
Computer-Aided Drug Design (CADD) has emerged as a fundamental component of modern drug discovery. Molecular docking facilitates virtual screening on a large scale through structural simulations. However, traditional CADD approaches face significant limitations, as they can only screen known compounds from existing libraries. PubChem, as the most widely used chemical ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Silent Cerebral Damage in Hypertension
Current Hypertension Reviews Microglial Integrity is Maintained by Erythropoietin Through Integration of Akt and Its Substrates of lycogen Synthase Kinase-3β, β-Catenin, and Nuclear Factor-κB
Current Neurovascular Research Molecular Pathways Involved in Apoptotic Cell Death in the Injured Cochlea: Cues to Novel Therapeutic Strategies
Current Pharmaceutical Design Angiogenesis and Blood-Brain Barrier Permeability in Vascular Remodeling after Stroke
Current Neuropharmacology Brain Perfusion In Sepsis
Current Vascular Pharmacology Herb-Drug Interactions in Neurological Disorders: A Critical Appraisal
Current Drug Metabolism Reduction in Ischemic Cerebral Infarction is Mediated through Golgi Phosphoprotein 3 and Akt/mTOR Signaling Following Salvianolate Administration
Current Neurovascular Research Short- and Long-Term Survival of Nonsurgical Intensive Care Patients and its Relation to Diagnosis, Severity of Disease, Age and Comorbidities
Current Aging Science CHF5074 Reduces Biomarkers of Neuroinflammation in Patients with Mild Cognitive Impairment: A 12-Week, Double-Blind, Placebo- Controlled Study
Current Alzheimer Research Recent Patents Review on Intranasal Administration for CNS Drug Delivery
Recent Patents on Drug Delivery & Formulation Medicinal Chemistry of Antimigraine Drugs
Current Medicinal Chemistry Non-Alcoholic Fatty Liver Disease and Vascular Disease
Current Vascular Pharmacology Investigating the Influence of Gut Microbiota-related Metabolites in Gastrointestinal Cancer
Current Cancer Drug Targets Cognitive Changes Preceding Clinical Symptom Onset of Mild Cognitive Impairment and Relationship to ApoE Genotype
Current Alzheimer Research Conference Report:5<sup>th</sup> International Conference on Nanotek & Expo, Nov 16-18, 2015, San Antonio TX, USA
CNS & Neurological Disorders - Drug Targets Lifestyle Modifications in the Treatment of Hypertension
Current Hypertension Reviews The Role of Mitochondrial Dysfunction in Heart Failure and Potential Therapeutic Targets
Current Pharmaceutical Design COVID19 - Far from Over: Call for Urgent Novel and Advanced Measures
Coronaviruses Silence of the Limbs: Pharmacological Symptomatic Treatment of Intermittent Claudication
Current Vascular Pharmacology Patent Selections
Recent Patents on Cardiovascular Drug Discovery